Optic Neuritis

Slide 1 · Optic neuritis

Demyelinating optic neuropathy and its pathology-based differential

Dr Abu Suraih Sakhri

MBBS, MD (Pathology)

www.abusuraihsakhri.com

Slide 2 · Learning objectives

Define optic neuritis precisely and identify the limits of the term.

Relate myelin injury and axonal preservation to visual dysfunction and recovery.

Explain associations with MS, AQP4-associated NMO and MOGAD.

Distinguish demyelination from ischemia, papilledema, glaucoma and hereditary injury.

Slide 3 · The optic nerve is a CNS tract

Retina

Optic nerve

Optic chiasm

CNS visual pathway

The optic nerve is a sensory tract of the central nervous system.

Its pathology has important parallels with diseases of the brain.

MS plaques may occur in the optic nerve and chiasm.

Slide 4 · Retinal ganglion-cell axons form the optic nerve

Axons

Retinal layers (schematic)

Retinal ganglion-cell axons converge at the optic nerve head.

Loss of those axons is an important structural manifestation of optic neuropathy.

Damage may occur in the nerve itself or in the retinal ganglion-cell pathway.

Slide 5 · Meninges and CSF surround the optic nerve

Optic nerve

CSF space

The optic nerve retains a meningeal investment.

Cerebrospinal fluid circulates within the surrounding space.

Elevated CSF pressure can therefore affect the optic disc.

Slide 6 · Optic neuropathy is broader than optic neuritis

Optic-nerve dysfunction

Demyelination

Ischemia

Raised CSF pressure

Glaucoma

Mitochondrial / toxic

Optic neuropathy denotes damage to the optic nerve, whatever the cause.

The chapter describes vascular, pressure-related, glaucomatous, hereditary, nutritional and toxic mechanisms.

Those causes must not be collapsed into a single inflammatory diagnosis.

Slide 7 · “Optic neuritis” has a historically broad meaning

Unrelated diseases have traditionally been grouped under this label.

The word “neuritis” suggests inflammation, which may not describe every underlying lesion.

An anatomically and mechanistically defined diagnosis is more informative.

Slide 8 · Robbins’ operational definition

Optic-nerve demyelination

Abnormal impulse transmission

Visual impairment

In everyday clinical usage, optic neuritis is visual loss due to demyelination of the optic nerve.

The definition identifies a lesion mechanism, not a single systemic cause.

MS is one important association, but not every first attack predicts MS.

Slide 9 · Demyelination and primary axonal injury differ

Intact myelin

Myelin loss / incomplete repair

Editable conceptual axon schematic, not a micrograph

Demyelinating disorders primarily damage myelin, initially with relative axonal preservation.

The optic nerve can also undergo ischemic infarction or irreversible axonal loss.

The dominant tissue compartment injured influences the prospects for recovery.

Slide 10 · Why loss of myelin impairs vision

Myelin loss

Impaired conduction

Visual loss

Myelin supports efficient transmission of electrical impulses along CNS axons.

Disruption of the sheath interferes with impulse propagation.

Optic-nerve dysfunction is clinically expressed as impaired vision.

Slide 11 · Myelin can be damaged while axons remain

Intact myelin

Myelin loss / incomplete repair

Editable conceptual axon schematic, not a micrograph

Active MS plaques typically show marked myelin loss with relative axonal preservation.

Axonal continuity may permit meaningful functional recovery.

The histologic pattern is not synonymous with complete tissue regeneration.

Slide 12 · Secondary axonal injury changes prognosis

Active myelin injury

Chronic gliosis

Axonal depletion

Some demyelinating processes are followed by secondary loss of axons.

Old gliotic MS plaques often show substantial axonal depletion.

Neuronal loss limits restoration of function even when acute inflammation wanes.

Slide 13 · Remyelination is limited in the CNS

Intact myelin

Myelin loss / incomplete repair

Editable conceptual axon schematic, not a micrograph

CNS tissue has limited capacity to regenerate normal myelin.

“Shadow plaques” may contain thin myelin sheaths consistent with incomplete remyelination.

Residual unmyelinated axons can persist in otherwise inactive lesions.

Slide 14 · An episode can resolve without systemic progression

Outcome after one attack

Visual recovery may occur

No further episodes in some

Follow-up is a separate question

Systemic disease trajectory

MRI lesions alter later MS risk

Subsequent events may establish MS

No automatic conversion

Slide 15 · MS is a major cause of demyelinating optic neuritis

Optic nerve

Visual impairment

Brainstem

Cranial-nerve signs

Spinal cord

Motor / sensory / sphincter

MS is an autoimmune CNS demyelinating disease.

The optic nerves and chiasm are among recognized sites of plaques.

Optic neuritis may precede other manifestations of MS.

Slide 16 · MS lesions are separated in space and time

Optic nerve event

Later or concurrent CNS lesion

Multiple sites / times

Robbins characterizes MS by distinct neurologic episodes separated in time.

Lesions are distributed at different sites within the CNS.

An isolated optic-nerve episode does not, by itself, demonstrate this pattern.

Slide 17 · Optic neuritis is often the initial MS manifestation

Optic nerve

Visual impairment

Brainstem

Cranial-nerve signs

Spinal cord

Motor / sensory / sphincter

Unilateral visual impairment due to optic nerve involvement is a frequent first manifestation.

Brainstem and spinal cord involvement can produce different neurologic deficits.

A subsequent clinical course may reveal dissemination beyond the optic nerve.

Slide 18 · A first optic neuritis episode is not an MS diagnosis

Only a proportion of people with optic neuritis subsequently develop MS.

Population-dependent progression estimates; They are not uniform individual risks.

A diagnosis requires attention to the subsequent clinical and CNS lesion pattern.

Slide 19 · Brain MRI modifies later MS risk

No brain lesions detected

Lower relative MS risk

Brain lesions detected

Higher relative MS risk

Association, not certainty

After a first optic neuritis episode, concomitant brain lesions on MRI predict greater 10-year MS risk.

MRI is a risk-stratification marker, not a deterministic prognosis.

The source excerpt provides no patient-specific numerical risk estimate.

Slide 20 · Interpret an MRI result as prognostic evidence

Brain lesions detected

Higher relative later MS risk

Evidence of wider CNS involvement

Not an automatic final diagnosis

No brain lesions detected

Lower relative risk than lesion-positive MRI

Single attack may remain isolated

Not a guarantee of zero risk

Slide 21 · The 10-year risk statement has limits

Lesion-positive MRI as a higher-risk state.

The size of risk depends on the population and study context.

Avoid transferring a cohort estimate directly to an individual without context.

Slide 22 · Visual recovery and conversion risk are separate

Attack-level outcome

Recovery of vision

Residual deficit possible

Depends on tissue injury

Disease-level outcome

Additional MS activity may occur

Baseline brain lesions alter risk

Remains uncertain after one event

Slide 23 · Why location drives the clinical syndrome in MS

Optic nerve

Visual impairment

Brainstem

Cranial-nerve signs

Spinal cord

Motor / sensory / sphincter

Optic-nerve lesions affect visual function.

Brainstem involvement may produce cranial nerve and ocular-motor signs.

Spinal cord lesions may cause motor, sensory and sphincter dysfunction.

Slide 24 · Relapsing–remitting MS: Attacks and recovery

Neurologic attack

Partial recovery

Possible new attack

Most people with MS initially experience variable relapsing and remitting episodes.

Deficits may be followed by gradual, often incomplete recovery.

An optic neuritis attack fits this wider relapsing CNS phenotype.

Slide 25 · MS may progress beyond relapses

Relapsing phase

Discrete inflammatory events

Periods of partial recovery

Treatment targets relapse prevention

Progressive phase

Ongoing neurologic deterioration

Chronic tissue injury contributes

Not reducible to attack count

Slide 26 · MS pathogenesis involves immune responses

Immune susceptibility

CNS inflammation

Myelin injury

The precise initiating self-antigen remains unresolved.

Genetic and environmental factors contribute to susceptibility.

Multiple inflammatory pathways can damage CNS myelin.

Slide 27 · B cells have a major role in MS

Autoantibodies

May bind glial antigens

Antigen presentation

Supports T-cell responses

Cytokines

Amplify inflammation

Clonal expansion

CSF immunologic footprint

Slide 28 · MS pathology: The active demyelinating plaque

Myelin breakdown / macrophages

Schematic lesion, not pathology evidence

Active lesions contain myelin breakdown and abundant foamy macrophages.

Perivascular lymphocytes, often near lesion margins, accompany inflammation.

The inflammatory lesion is primarily a pathologic model for MS-related demyelination.

Slide 29 · Active plaque: Axons are relatively preserved

Intact myelin

Myelin loss / incomplete repair

Editable conceptual axon schematic, not a micrograph

Myelin can be nearly absent in the active lesion.

Axons initially remain much better preserved than myelin.

This distinction helps explain why a transient clinical deficit need not equal total axonal destruction.

Slide 30 · Inactive plaque: Gliosis and axonal attrition

Gliosis / axonal loss

Schematic lesion, not pathology evidence

Macrophages and overt inflammation become sparse.

Reactive astrocytic gliosis becomes prominent.

Old plaques can show markedly decreased axon density.

Slide 31 · “Shadow plaques” suggest incomplete repair

Intact myelin

Myelin loss / incomplete repair

Editable conceptual axon schematic, not a micrograph

Some plaques show reduced pallor and thinner myelin sheaths.

These represent limited remyelination rather than full restoration.

Partially repaired regions may coexist with persistent tissue injury.

Slide 32 · Stages of an MS demyelinating lesion

Active plaque

Quiescent gliosis

Partial remyelination

Early injury emphasizes myelin loss and inflammatory cells.

Over time, inflammatory infiltrates may recede while gliosis persists.

Partial remyelination is possible but often incomplete.

Slide 33 · CSF findings support the MS context

Expanded B-cell clones

Intrathecal IgG bands

Supportive CNS evidence

CSF IgG is often increased; Oligoclonal IgG bands are commonly observed.

The bands reflect an expanded CNS B-cell response.

CSF studies supplement—not replace—clinical and MRI interpretation.

Slide 34 · MRI is central to assessing demyelinating disease

No brain lesions detected

Lower relative MS risk

Brain lesions detected

Higher relative MS risk

Association, not certainty

Brain MRI can demonstrate lesions accompanying an initial optic neuritis event.

MRI in monitoring the course of MS.

MRI findings must be linked to the optic neuritis clinical setting.

Slide 35 · Therapy in MS addresses systemic disease activity

Immunomodulatory and immunosuppressive treatment.

B-cell–depleting anti-CD20 therapy is highlighted for relapse control.

Controlling relapses does not completely eliminate late neurodegenerative progression.

Slide 36 · Neuromyelitis optica links optic nerves and spinal cord

Optic nerve

Visual impairment

Brainstem

Cranial-nerve signs

Spinal cord

Motor / sensory / sphincter

The source describes a syndrome with synchronous or nearly synchronous bilateral optic neuritis and spinal cord demyelination.

Recovery after the initial attack is often poorer than in MS.

Its immunopathologic substrate differs from typical MS.

Slide 37 · AQP4 antibodies identify an astrocyte-targeted disease

Astrocyte (schematic)

AQP4

Astrocyte injury

→ myelin damage

Most NMO cases have pathogenic anti-aquaporin-4 antibodies.

Aquaporin-4 is a major astrocytic water channel.

The primary target is the astrocyte; Demyelination occurs downstream.

Slide 38 · AQP4 injury can precede myelin destruction

Anti-AQP4 antibodies

Astrocyte / BBB injury

Secondary demyelination

Antibodies damage astrocytes and the blood–brain barrier.

The resulting astrocytopathy initiates inflammatory tissue injury.

Myelin damage is secondary in this mechanistic model.

Slide 39 · Complement contributes to AQP4-associated injury

Antibody binding

Complement and inflammation

Necrotizing tissue injury

Damaged white matter can show vascular immunoglobulin and complement deposition.

Neutrophils and eosinophils may accompany the inflammatory infiltrate.

This tissue pattern separates AQP4-associated disease from a generic myelin-only model.

Slide 40 · NMO tissue changes can be destructive

Necrosis

Destructive white-matter injury

Inflammation

Including neutrophils / eosinophils

Immune deposits

Vascular Ig and complement

AQP4 loss

Astrocyte-targeted pattern

Slide 41 · MOGAD is not equivalent to AQP4-associated NMO

AQP4-associated disease

Antibody target: Astrocytic AQP4

Primary astrocytopathy

Female predominance described

MOG-associated disease

Antibody target: MOG

Different immune target

No female predominance in source

Slide 42 · MOGAD has a distinct natural-history context

The chapter describes MOGAD as more likely to be monophasic than AQP4-NMO.

It may present with acute disseminated encephalomyelitis.

The chapter highlights a predilection for children and young adults in that presentation.

Slide 43 · Antibody target changes the pathogenetic model

Optic-nerve dysfunction

MS: Complex autoimmunity

AQP4: Astrocyte channel

MOG: Myelin-associated antigen

AQP4-associated disease begins with an astrocytic antigen.

MOGAD is associated with an antibody directed against a myelin protein.

Both may enter the differential of optic-neuritis-associated demyelination.

Slide 44 · Treatment concepts in AQP4-associated NMO

Acute inflammatory attack

Suppress / remove antibodies

Prevent further injury

Glucocorticoids or plasma exchange for acute attacks.

Long-term strategies reduce pathogenic antibodies or inhibit complement.

These are systemic-disease principles; This deck provides no drug doses or protocol.

Slide 45 · Not all optic neuropathy reflects demyelination

Optic-nerve dysfunction

Demyelinating

Ischemic

Pressure-related

Glaucomatous

Hereditary / toxic

The shared clinical endpoint is impaired visual function.

Other mechanisms include interrupted perfusion, altered CSF pressure and axonal degeneration.

Mechanistic classification prevents misleading use of the optic-neuritis label.

Slide 46 · AION: Ischemia is the initiating lesion

Reduced blood flow

Ischemic nerve dysfunction

Infarction if severe

Anterior ischemic optic neuropathy spans transient ischemia through infarction.

Partial interruption of blood supply may produce transient visual loss.

Sustained severe vascular compromise can permanently injure the nerve.

Slide 47 · Incomplete ischemia and infarction differ

Viable ischemic zone

Reduced perfusion

Potential functional recovery

Injury may be transient

Infarcted nerve tissue

Irreversible tissue injury

No regeneration

Permanent visual deficit

Slide 48 · AION can reflect vascular inflammation

Vascular insult

Optic-nerve hypoperfusion

Potential infarction

Inflammation of feeding vessels can reduce optic-nerve blood flow.

Thrombotic or embolic events are other described mechanisms.

Temporal arteritis is an urgent cause because bilateral optic-nerve infarcts and blindness can occur.

Slide 49 · Papilledema: Pressure affects axoplasmic transport

Optic nerve

CSF space

Increased CSF pressure can compress the optic nerve circumferentially.

Venous stasis and impaired axoplasmic transport produce optic-nerve-head edema.

Raised pressure classically causes bilateral disc swelling.

Slide 50 · Papilledema and visual loss are not synonymous

Papilledema from raised CSF pressure

Usually bilateral disc edema

Acute vision commonly preserved

Swelling from venous / axoplasmic stasis

Demyelinating optic neuritis

Visual impairment from myelin injury

Need not share same disc mechanism

Systemic demyelination may coexist

Slide 51 · Pale versus hyperemic swelling: A pathology clue

AION

Pale swollen disc

Papilledema

Hyperemic swollen disc

Color-coded diagram is schematic—not a fundus photograph

In acute AION, the swollen optic nerve head is relatively pale due to diminished perfusion.

In papilledema, the swollen disc is typically hyperemic.

The comparison is a conceptual clue—not an exhaustive bedside algorithm.

Slide 52 · Compression may also produce disc edema

Optic-nerve tumor

Local compression

Unilateral disc edema

A primary optic-nerve mass may cause unilateral nerve-head swelling.

The chapter lists glioma and meningioma as principal optic-nerve neoplasms.

Laterality and anatomical context can redirect the differential.

Slide 53 · Glaucoma causes chronic ganglion-cell loss

Glaucoma may damage optic-nerve axons through a pressure-dependent pathway.

Individual susceptibility varies; Some injury occurs despite normal pressure.

The result is a chronic optic neuropathy, not the demyelination discussed in optic neuritis.

Slide 54 · Advanced glaucoma combines atrophy and cupping

Normal disc: Small cup

Advanced glaucoma: Enlarged cup

Retinal ganglion cells and retinal nerve fiber layer become depleted.

The optic nerve head cup enlarges and deepens.

This combination of cupping and atrophy is characteristic of advanced glaucoma.

Slide 55 · OCT demonstrates structural loss in glaucoma

Glaucomatous pathology

Ganglion-cell depletion

Nerve fiber layer thinning

Optic-disc cupping

Demyelinating pathology

Loss of optic-nerve myelin

Initially relative axonal preservation

Variable later axon damage

Slide 56 · Toxic and nutritional optic neuropathies

Nutritional deficiency and toxins, including methanol, can cause optic-nerve injury.

Central visual acuity is particularly compromised if macular-origin fibers are affected.

A toxic or metabolic history changes the disease mechanism under consideration.

Slide 57 · Leber hereditary optic neuropathy: Mitochondrial

Mitochondrial mutation

Neuronal energetic vulnerability

Optic neuropathy

Leber hereditary optic neuropathy involves mitochondrial DNA mutations.

Maternal inheritance reflects mitochondrial transmission.

The chapter describes a male predominance and usual onset between ages 10 and 30.

Slide 58 · Why mitochondrial injury affects optic neurons

Reduced mitochondrial function

Axonal metabolic vulnerability

Visual dysfunction

Neurons depend on mitochondrial oxidative phosphorylation.

Mitochondrial dysfunction therefore particularly threatens optic-nerve function.

Inherited optic neuropathy should not be relabeled inflammatory without evidence.

Slide 59 · Mechanism-based differential at a glance

Mechanism

Underlying lesion

Interpretive context

Demyelinating

Myelin injury

MS / NMO / MOGAD context

Ischemic

Hypoperfusion → infarction

AION; Temporal arteritis

Pressure-related

CSF pressure → transport stasis

Papilledema

Degenerative

Ganglion-cell / axon loss

Glaucoma

Inherited/toxic

Mitochondrial or toxic injury

LHON; Methanol

Slide 60 · Case application: First optic neuritis episode

CLINICAL REASONING

A patient has a single demyelinating optic-nerve episode.

Brain MRI shows additional CNS lesions.

Question: What does the MRI contribute—and what does it not establish by itself?

INTERPRETATION

Brain lesions increase subsequent MS risk; A single attack and an imaging marker should not be described as inevitable MS progression.

Slide 61 · Case application: Isolated attack and recovery

CLINICAL REASONING

A first episode of optic nerve demyelination resolves.

No subsequent neurologic attacks are yet documented.

Question: Does recovery confirm or exclude future MS?

INTERPRETATION

Neither. Robbins explicitly allows recovery and a disease-free course after one episode; Longer-term risk is a separate outcome.

Slide 62 · Case application: Optic nerves plus myelitis

CLINICAL REASONING

A patient has nearly synchronous bilateral optic neuritis and spinal cord disease.

Question: Which immune-mediated syndrome deserves specific consideration?

What antigenic target makes its mechanism distinctive?

INTERPRETATION

NMO phenotype; Test the AQP4-associated astrocytopathy model, while recognizing MOG antibody-associated disease as a distinct possibility.

Slide 63 · Case application: Two swollen optic discs

CLINICAL REASONING

One presentation shows bilateral hyperemic optic-disc swelling.

Another shows a swollen but pale optic nerve head.

Question: Which pathological mechanisms are classically linked to these appearances?

INTERPRETATION

Bilateral hyperemic papilledema suggests raised CSF pressure; Pale swelling supports ischemic optic neuropathy. These clues do not replace full assessment.

Slide 64 · Pathogenesis synthesis: Five distinct mechanisms

Mechanism

Underlying lesion

Interpretive context

Myelin

MS-related demyelination

Initially preserved axons

Astrocyte

AQP4-associated injury

Secondary myelin loss

Vascular supply

AION

Viability versus infarction

Pressure / transport

Papilledema

Swelling without typical acute loss

Axon / metabolism

Glaucoma or LHON

Chronic / metabolic dysfunction

Slide 65 · Clinical synthesis: What a first attack tells us

A first optic neuritis episode establishes a possible focal demyelinating event.

Associated brain MRI lesions increase later MS risk.

A first attack can recover without subsequent MS; Do not equate risk with certainty.

Competing optic-neuropathy mechanisms require deliberate exclusion.

Slide 66 · References and source boundary

Robbins, Cotran & Kumar. Pathologic Basis of Disease. 11th ed. (2026).

Chapter 29: The Eye—Optic Nerve and Optic Neuritis (pp. 1207–1209).

Chapter 28: The Central Nervous System—demyelinating diseases and MS (pp. 1156–1158).

Conceptual schematics are original PowerPoint shapes—not patient images or tissue specimens.